ZELLULAERE IMMUNITAET BEI DIABETES MELLITUS = IMMUNITE CELLULAIRE AU COURS DU DIABETELUGER T; MICKSCHE M.1978; WIEN. MED. WSCHR.; AUT; DA. 1978; VOL. 128; NO 20; PP. 656-659; BIBL. 34 REF.Article

Treatment of immune-mediated skin diseases: future perspectivesLUGER, T.EJD. European journal of dermatology. 2001, Vol 11, Num 4, pp 343-347, issn 1167-1122Article

VITILIGO DU AU PARATERTIAIRE BUTYLPHENOLGEBHART W; LUGER T; NIEBAUER G et al.1980; ANN. DERMATOL. VENEREOL.; ISSN 0151-9638; FRA; DA. 1980; VOL. 107; NO 8-9; PP. 809-814; BIBL. 19 REF.Article

IMMUNO-CHEMOTHERAPIE BEI PATIENTEN MIT DISSEMINIERT METASTASIERENDEM MELANOM STADIUM III. RANDOMISIERTE STUDIE MIT METHYL-CCNU VERSUS C. PARVUM PLUS METHYL-CCNU = IMMUNOCHIMIOTHERAPIE CHEZ LES MALADES AVEC MELANOME AU STADE III AVEC METASTASES DISSEMINEES. ETUDE RANDOMISEE COMPARANT LE METHYL CCNU AVEC C.P+METHYL CCNUKOKOSCHKA EM; LUGER T; MICKSCHE M et al.1978; ONKOLOGIE; DEU; DA. 1978; VOL. 1; NO 3; PP. 98-103; ABS. ENG; BIBL. 34 REF.Article

Epidermal cytokinesLUGER, T. A.Acta dermato-venereologica. Supplementum. 1989, Vol 69, Num 151, pp 61-76, issn 0365-8341, 16 p., supplConference Paper

GENODERMATOSE BEI EINEM BRUEDERPAAR: MORBUS DOWLING-DEGOS, GROVER, DARIER, HAILEY-HAILEY ODER GALLI-GALLI. = GENODERMATOSE CHEZ DEUX FRERES: MALADIE DE DOWLING-DEGOS, GROVER, DARIER, HAILEY-HAILEY OU GALLI-GALLI.BARDACH H; GEBHART W; LUGER T et al.1982; HAUTARZT; ISSN 0017-8470; DEU; DA. 1982; VOL. 33; NO 7; PP. 378-383; ABS. ENG; BIBL. 19 REF.Article

ALTERATIONS PILAIRES AU COURS D'UNE NEUROPATHIE AXONALE GEANTELUGER T; GEBHART W; SLUGA E et al.1979; ANN. DERMATOL. VENEREOL.; FRA; DA. 1979; VOL. 106; NO 11; PP. 893-898; BIBL. 20 REF.Article

The skin associated immune systemLUGER, T. A.Pathologie et biologie. 1994, Vol 42, Num 1, pp 81-82, issn 0369-8114Conference Paper

DERMATOSE ACANTHOLYTIQUE TRANSITOIRE (GROVER)HORN E; GEBHART W; LUGER T et al.1978; ANN. DERMATOL. VENEREOL.; FRA; DA. 1978; VOL. 105; NO 6-7; PP. 581-585; ABS. ENG; BIBL. 17 REF.Article

The role of cytokines and neuroendocrine hormones in cutaneous immunity and inflammationLUGER, T. A; SCHWARZ, T.Allergy (Copenhagen). 1995, Vol 50, Num 4, pp 292-302, issn 0105-4538Article

Effect of UV irradiation on epidermal cell cytokine productionSCHWARZ, T; LUGER, T. A.Journal of photochemistry and photobiology. B, Biology. 1989, Vol 4, Num 1, pp 1-13, issn 1011-1344, 13 p.Article

Österreichische Dermatologische Gesellschaft. Administrative und wissenschaftliche Sitzung am 17. November 1984 in WienNIEBAUER, G; LUGER, T. A.Hautarzt. 1986, Vol 37, Num 12, pp 679-683, issn 0017-8470Article

Therapeutic use of cytokines in dermatologyLUGER, T. A; SCHWARZ, T.Journal of the American Academy of Dermatology. 1991, Vol 24, Num 6, pp 915-926, issn 0190-9622, 12 p., p.1Article

Immunmodulation durch ein epidermales Zytokin (ETAF) = Immunomodulation par une cytokine (ETAF) épidermique = Immunomodulation by an epidermal cytokine (ETAF)LUGER, T. A; NIEBAUER, G.H + G. Zeitschrift für Hautkrankheiten. 1984, Vol 59, Num 1, pp 18-34, issn 0301-0481Article

HUMAN TEAR LYSOZYME. A COMPARISON OF ELECTRO-IMMUNODIFFUSION, RADIAL IMMUNODIFFUSION AND A SPECTROPHOTOMETRIC ASSAYGRABNER G; FORMANEK I; DORDA W et al.1982; GRAEFE'S ARCH. CLIN. EXP.. OPHTHALMOL.; ISSN 0721-832X; DEU; DA. 1982; VOL. 218; NO 5; PP. 265-270; ABS. GER; BIBL. 38 REF.Article

Alpha-Melanozyten stimulierendes Hormon : Seine aktuelle Bedeutung für die Dermatologie : Endokrinologie = Alpha-melanocyte-stimulating hormone. Its relevance for dermatology : EndocrinologyBÖHM, M; LUGER, T. A.Hautarzt. 2004, Vol 55, Num 5, pp 436-445, issn 0017-8470, 8 p.Article

Oxygen application by a nasal probe prevents hypoxia but not rebreathing of carbon dioxide in patients undergoing eye surgery under local anaesthesiaSCHLAGER, A; LUGER, T. J.British journal of ophthalmology. 2000, Vol 84, Num 4, pp 399-402, issn 0007-1161Article

Ultrastructural localization of carcinoembryonic antigen (CEA) glycoproteins and epithelial membrane antigen (EMA) in normal and neoplastic sweat glandsMETZE, D; LUGER, T. A.Journal of cutaneous pathology. 1996, Vol 23, Num 6, pp 518-529, issn 0303-6987Article

Human keratinocytes and epidermoid carcinoma cell lines produce a cytokine with interleukin 3-like activityDANNER, M; LUGER, T. A.Journal of investigative dermatology. 1987, Vol 88, Num 4, pp 353-361, issn 0022-202XArticle

Administrative jahressitzung und wissenschaftliche Sitzung der Österreichischen Dermatologischen Gesellschaft am 17. November 1984 in WienNIEBAUER, G; LUGER, T. A.H + G. Zeitschrift für Hautkrankheiten. 1986, Vol 61, Num 15, pp 1107-1119, issn 0301-0481, 11 p.Conference Paper

Zytokine, Stand und Perspektiven in der Behandlung von Hauttumoren = Cytokines - current status and perspectives in the treatment of skin tumorsNASHAN, D; LUGER, T. A.Hautarzt. 2001, Vol 52, Num 8, pp 691-696, issn 0017-8470Article

Interleukin 1. Teil 2: Wirkungsmechanismen und therapeutische Möglichkeiten = Interleukin 1. Part 2 : Mode of action and therapeutic possibilitiesNASHAN, D; LUGER, T. A.Hautarzt. 1999, Vol 50, Num 10, pp 756-763, issn 0017-8470Article

Cytokines épidermiques et lumière ultraviolette = Epidermal cytokines and ultraviolet-lightLUGER, T. A.Les Nouvelles dermatologiques. 1994, Vol 13, Num 5, pp 262-266, issn 0752-5370Conference Paper

Identification of α₂-macroglobulin as a cytokine binding plasma protein: binding of interleukin-1β to Fα₂-macroglobulinBORTH, W; LUGER, T. A.The Journal of biological chemistry (Print). 1989, Vol 264, Num 10, pp 5818-5825, issn 0021-9258Article

SERUM LYSOZYME LEVELS IN PATIENTS WITH SOLID TUMORSLUGER T; KOKOSCHKA EM; SAGASTER P et al.1979; ONCOLOGY; CHE; DA. 1979; VOL. 36; NO 1; PP. 15-18; BIBL. 19 REF.Article